PlainRecalls
FDA Drug Moderate Class II Ongoing

Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03

Reported: December 31, 2025 Initiated: December 12, 2025 #D-0241-2026

Product Description

Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03

Reason for Recall

Presence of particulate matter: potential presence of metal particulates in the product.

Details

Recalling Firm
Merck Sharp & Dohme LLC
Units Affected
3 - single dose kits
Distribution
Nationwide in the USA
Location
Wilson, NC

Frequently Asked Questions

What product was recalled?
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03. Recalled by Merck Sharp & Dohme LLC. Units affected: 3 - single dose kits.
Why was this product recalled?
Presence of particulate matter: potential presence of metal particulates in the product.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 31, 2025. Severity: Moderate. Recall number: D-0241-2026.